Alzheimer’s Research & Therapy (Sep 2024)

Neuropsychiatric symptoms and lifelong mental activities in cerebral amyloid angiopathy – a cross-sectional study

  • Marc Dörner,
  • Anthony Tyndall,
  • Nicolin Hainc,
  • Roland von Känel,
  • Katja Neumann,
  • Sebastian Euler,
  • Frank Schreiber,
  • Philipp Arndt,
  • Erelle Fuchs,
  • Cornelia Garz,
  • Wenzel Glanz,
  • Michaela Butryn,
  • Jan Ben Schulze,
  • Sarah Lavinia Florence Schiebler,
  • Anna-Charlotte John,
  • Annkatrin Hildebrand,
  • Andreas B. Hofmann,
  • Lena Machetanz,
  • Johannes Kirchebner,
  • Pawel Tacik,
  • Alexander Grimm,
  • Robin Jansen,
  • Marc Pawlitzki,
  • Solveig Henneicke,
  • Jose Bernal,
  • Valentina Perosa,
  • Emrah Düzel,
  • Sven G. Meuth,
  • Stefan Vielhaber,
  • Hendrik Mattern,
  • Stefanie Schreiber

DOI
https://doi.org/10.1186/s13195-024-01519-3
Journal volume & issue
Vol. 16, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background While several studies in cerebral amyloid angiopathy (CAA) focus on cognitive function, data on neuropsychiatric symptoms (NPS) and lifelong mental activities in these patients are scarce. Since NPS are associated with functional impairment, faster cognitive decline and faster progression to death, replication studies in more diverse settings and samples are warranted. Methods We prospectively recruited n = 69 CAA patients and n = 18 cognitively normal controls (NC). The number and severity of NPS were assessed using the Alzheimer’s Disease (AD) Assessment Scale’s (ADAS) noncognitive subscale. We applied different regression models exploring associations between NPS number or severity and group status (CAA vs. NC), CAA severity assessed with magnetic resonance imaging (MRI) or cognitive function (Mini-Mental State Examination (MMSE), ADAS cognitive subscale), adjusting for age, sex, years of education, arterial hypertension, AD pathology, and apolipoprotein E status. Mediation analyses were performed to test indirect effects of lifelong mental activities on CAA severity and NPS. Results Patients with CAA had 4.86 times (95% CI 2.20-10.73) more NPS and 3.56 units (95% CI 1.94–5.19) higher expected NPS severity than NC. Higher total CAA severity on MRI predicted 1.14 times (95% CI 1.01.-1.27) more NPS and 0.57 units (95% CI 0.19–0.95) higher expected NPS severity. More severe white matter hyperintensities were associated with 1.21 times more NPS (95% CI 1.05–1.39) and 0.63 units (95% CI 0.19–1.08) more severe NPS. NPS number (MMSE mean difference − 1.15, 95% CI -1.67 to -0.63; ADAS cognitive mean difference 1.91, 95% CI 1.26–2.56) and severity (MMSE − 0.55, 95% CI -0.80 to -0.30; ADAS cognitive mean difference 0.89, 95% CI 0.57–1.21) predicted lower cognitive function. Greater lifelong mental activities partially mediated the relationship between CAA severity and NPS (indirect effect 0.05, 95% CI 0.0007-0.13), and greater lifelong mental activities led to less pronounced CAA severity and thus to less NPS (indirect effect − 0.08, 95% CI -0.22 to -0.002). Discussion This study suggests that NPS are common in CAA, and that this relationship may be driven by CAA severity. Furthermore, NPS seem to be tied to lower cognitive function. However, lifelong mental activities might mitigate the impact of NPS in CAA.

Keywords